Navigation Links
Novel chemistry for new class of antibiotic
Date:7/3/2013

University of Adelaide research has produced a potential new antibiotic which could help in the battle against bacterial resistance to antibiotics.

The potential new antibiotic targets a bacterial enzyme critical to metabolic processes.

The compound is a protein inhibitor which binds to the enzyme (called biotin protein ligase), stopping its action and interrupting the life cycle of the bacteria.

"Existing antibiotics target the bacterial cell membranes but this potential new antibiotic operates in a completely different way," says Professor Andrew Abell, project leader and Acting Head of the University's School of Chemistry and Physics.

Professor Abell says the compound, although at a very early stage of development it has not yet been tested on an animal model has the potential to become the first of a new class of antibiotics.

"Bacteria quickly build resistance against the known classes of antibiotics and this is causing a significant global health problem," he says. "Preliminary results show that this new class of compound may be effective against a wide range of bacterial diseases, including tuberculosis which has developed a strain resistant to all known antibiotics."

Developing the new protein inhibitor involved a novel approach called 'in situ click chemistry'. A selection of small molecules, or 'precursor fragments', are presented to the bacteria in a way so that the target protein enzyme itself builds the inhibiting compound and also binds with it.

"In a sense the bacteria unwittingly chooses a compound that will stop its growth and assembles it like building a weapon and using it against itself," says Professor Abell. "We've gone a step further to specifically engineer the enzyme so that it builds the best and most potent weapon."

"Our results are promising. We've made the compounds; we know they bind and inhibit this enzyme and we've shown they stop the growth of a range of bacteria in the laboratory. The next critical step will be investigating their efficacy in an animal model."

"Thanks to this new approach what might have taken a year or more with a range of sequential experiments, we can now do in one single experiment," Professor Abell says.


'/>"/>

Contact: Professor Andrew Abell
andrew.abell@adelaide.edu.au
61-416-389-220
University of Adelaide
Source:Eurekalert

Related biology news :

1. Researchers discover novel therapy for Crohns disease
2. New clinical trial explores novel noninvasive colon cancer screening test
3. Notre Dame researchers using novel method to combat malaria drug resistance
4. Unique adaptations to a symbiotic lifestyle reveal novel targets for aphid insecticides
5. Key proteins newly discovered form and function may provide novel cancer treatment target
6. Novel discovery by NUS scientists paves the way for more effective treatment of cancers
7. London researchers discover novel mechanism involved in key immune response
8. Mexican rock heroes trial novel green trading system
9. VTT and GE Healthcare developing novel biomarkers to predict Alzheimers disease
10. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
11. Novel nano-structures to realize hydrogens energy potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... 2017  The Allen Institute for Cell Science today ... one-of-a-kind portal and dynamic digital window into the human ... first application of deep learning to create predictive models ... and a growing suite of powerful tools. The Allen ... future publicly available resources created and shared by the ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... 2017  higi, the health IT company that operates ... America , today announced a Series B investment ... EveryMove. The new investment and acquisition accelerates higi,s strategy ... transform population health activities through the collection and workflow ... higi collects and secures data today on behalf of ...
Breaking Biology News(10 mins):
(Date:5/26/2017)... ... May 25, 2017 , ... Throughout this webinar, participants will ... process development and economic goals were achieved in both industry and academic settings. ... system, along with techniques for scaling production of mesenchymal stem cells (MSCs) and ...
(Date:5/24/2017)... BOUNTIFUL, Utah (PRWEB) , ... May 24, 2017 ... ... announces the selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery ... a key component of a $24 million plant upgrade to sustainably meet current ...
(Date:5/24/2017)... May 23, 2017 As Ebola resurfaces in the ... deaths and 20 suspected cases now reported, a new analysis ... database, showed a correlation between the 2014 and 2017 outbreaks ... rose sharply in 2012-13, which preceded the 2014 outbreak. An ... Ebola gene Replikin counts in 2014-15, which again precedes the ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
Breaking Biology Technology: